Skip to main content

LeMaitre Vascular Inc Value Stock - Dividend - Research Selection

LeMaitre Vascular Inc

ISIN: US5255582018, WKN: A0LB2B

Market price date: 26.01.2022
Market price: 41,98 USD


LeMaitre Vascular Inc Fundamental data and company key figures of the share

Annual reports in USD
Key figures 04-10-2021
Cash flow
Net operating cash flow 34.800.000
Capital Expenditures -2.982.000
Free cash flow 31.818.000
Balance sheet
Total Equity 172.572.000
Liabilities & Shareholders equity 252.810.000
Income statement
Net income 21.220.000
Eps (diluted) 1,048
Diluted shares outstanding 20.254.000
Net sales/revenue 129.366.000

Fundamental ratios calculated on: 26-01-2022

Ratios
Key figures 26-01-2022
Cash flow
P/C 24,43
   
P/FC 26,72
Balance sheet
ROI8,39
ROE68,26
Income statement
P/E40,07
Div. Yield0,91%
P/B4,93
P/S6,57


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolLMAT
Market Capitalization850.262.912,00 USD
CountryUnited States
IndicesNO INDEX
SectorsHealth Care Equipment
Raw Data SourceUS GAAP in Millionen USD
Stock Split
Internetwww.lemaitre.com


Description of the company

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular patches, which are used for closure of vessels after surgical intervention; closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.lemaitre.com


NEWS


What to watch today: Stock futures turn positive, reversing big overnight losses

2022-01-27
Dow futures turned positive Thursday after falling more than 500 points overnight.

5 things to know before the stock market opens Thursday

2022-01-27
Dow futures turned positive Thursday after falling more than 500 points overnight as the market's recent volatility persisted.

Stocks making the biggest moves premarket: McDonald's, Blackstone, Netflix and others

2022-01-27
These are the stocks posting the largest moves before the bell.

Comcast reports better-than-expected Q4 earnings, raises dividend

2022-01-27
CNBC's 'Squawk Box' team break down the last fourth-quarter earnings report from Comcast.

Comcast beats earnings expectations, but falls short on new internet customers

2022-01-27
Comcast Cable's CEO during an event last month predicted a full-year number that fell below estimates.

Here's Why I Think LeMaitre Vascular (NASDAQ:LMAT) Might Deserve Your Attention Today

2022-01-26
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks with a good story, even if those businesses lose money. And in their study titled Who Falls Prey to the Wolf of Wall Street?' Leuz et. al. found that it is 'qu

Earnings playbook: A complete guide to this week's reports, including the first of tech

2022-01-23
Microsoft, Tesla and Apple will release quarterly results, alongside a handful of other tech firms. McDonald's and Boeing will also offer updates.

Markets are expected to remain on edge as the Fed meets in the week ahead

2022-01-21
The Federal Reserve's meeting trumps everything else for markets in the week ahead, as investors await any new clues on its plans to raise interest rates.

Netflix quietly admits streaming competition is eating into growth

2022-01-20
Netflix added a line in its quarterly shareholder letter acknowledging streaming competition is affecting its "marginal growth."

Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media

2022-01-18
Microsoft takes big $68.7 billion swing on video game company Activision Blizzard while legacy media stays on sidelines